Kymera Therapeutics, Inc.

NASDAQ:KYMR

49.03 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -146.962-154.808-100.217-45.593-41.246-21.467
Depreciation & Amortization 3.5652.9772.3971.7630.8250.205
Deferred Income Tax -2.682001.57100
Stock Based Compensation 43.11835.4824.9725.191.1960.648
Change In Working Capital 2.682-37.623-61.923124.86756.6872.308
Accounts Receivables -15-2.4010.577-0.5770.148-0.148
Inventory 23.3722.4018.7086.879-0.1480
Accounts Payables 2.0380.2530.0540.990.9040.824
Other Working Capital -7.728-37.876-71.262117.57555.7831.484
Other Non Cash Items -2.5470.8895.8250.3320.4430.443
Operating Cash Flow -102.826-153.085-128.94688.1317.905-17.863
Investing Activities:
Investments In Property Plant And Equipment -34.48-2.836-1.597-9.096-0.532-1.356
Acquisitions Net -5.229-20.5195.807413.49200
Purchases Of Investments -189.151-445.972-456.404-529.382-15.9540
Sales Maturities Of Investments 363.517469.327358.166115.8900
Other Investing Activites 5.22920.519-5.807-413.492-15.9540
Investing Cash Flow 139.88620.519-99.835-422.588-16.486-1.356
Financing Activities:
Debt Repayment -0.076-1.13-0.849-0.554-0.371-0.295
Common Stock Issued 4.268149.825243.106196.67335.28253.227
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 4.2684.3048.02393.14334.91153.227
Financing Cash Flow 4.192152.999250.28289.26234.91152.932
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 41.25220.43321.499-45.19636.3333.713
Cash At End Of Period 115.77774.52554.09232.59377.78941.459